Oslo, Norway

Tore Skjaeret

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tore Skjaeret

Introduction

Tore Skjaeret is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aromatic compounds. His work focuses on creating compounds that have potential therapeutic applications for various metabolic and liver diseases.

Latest Patents

Tore Skjaeret holds a patent for "Aromatic compounds and pharmaceutical uses thereof." This patent describes compounds of a general formula that can be utilized in pharmaceutical compositions. The compounds are designed for use as medicaments, particularly for treating diseases such as non-alcoholic fatty liver disease and cholestasis diseases. The patent emphasizes the versatility of the compounds, which can include various substituents and derivatives.

Career Highlights

Tore Skjaeret is associated with BASF AS, a leading company in the chemical industry. His work at BASF AS has allowed him to explore innovative solutions in the pharmaceutical sector. With a focus on research and development, he has contributed to advancements that aim to improve health outcomes for patients suffering from metabolic disorders.

Collaborations

Tore Skjaeret collaborates with David Alan Fraser, enhancing the research and development efforts within their field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in pharmaceutical research.

Conclusion

Tore Skjaeret's contributions to the field of pharmaceuticals through his innovative patent and collaboration with colleagues highlight the importance of research in addressing health challenges. His work continues to pave the way for new therapeutic options in treating complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…